331. Development of Neisseria Meningitidis CRISPR/Cas9 Systems for Efficient and Specific Genome Editing
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33940-5
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Elsevier BV